WOMEN'S ISCHEMIC SYMPTOM EVALUATION (WISE)

女性缺血症状评估（WISE）

• 批准号: 6117207
• 负责人: Cathleen Noel Bairey Merz
• 金额: $ 3.89万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6117207
• 关键词: clinical research; female; heart disorder; hormones; human subject; ischemia; pathologic process; sign /symptom; vasoconstriction; women's health

The WISE is a multi-center study designed to help understand heart disease in women via studies of vasoconstriction, cardiac blood flow, questionnaire cardiac symptomatology, and measurement of circulatory hormone levels. Women are being recruited for this study at the University of Pittsburgh, University of Florida, University of Alabama, and Allegheny General Hospital. Cedars-Sinai is functioning as the core laboratory for the blood hormone determinations. Blood samples are shipped from the four study sites to the GCRC at Cedars-Sinai, where they are collated and triaged to the appropriate laboratories for hormone analysis.

WISE是一项多中心研究，旨在帮助了解心脏 通过对血管收缩、心脏血流量 问卷调查心脏血管病学，并测量循环 荷尔蒙水平 正在招募妇女参加这项研究， 匹兹堡大学、佛罗里达大学、亚拉巴马大学、 阿勒格尼综合医院 雪松-西奈半岛是 血液激素测定实验室。 血样 从四个研究中心运送至Cedars-Sinai的GCRC， 它们被整理和分类到适当的实验室， 激素分析